quantisnow
FeedTopReportsPricing
⌘K
Live feed
00:15:25·710d
SECFiling
Gamida Cell Ltd. logo

SEC Form EFFECT filed by Gamida Cell Ltd.

GMDA· Gamida Cell Ltd.
Health Care
Original source

Companies

  • GMDA
    Gamida Cell Ltd.
    Health Care

Recent analyst ratings

  • Nov 16UpdateNeedham$12.00
  • Nov 16UpdateOppenheimer$15.00
  • Nov 1UpdateAlliance Global Partners$11.00

Related

  • PR346d
    Purple Biotech Appoints Shai Lankry as Chief Financial Officer
  • PR640d
    HOOKIPA Pharma Announces Leadership Changes to Intensify Focus on HB-200
  • SEC710d
    SEC Form EFFECT filed by Gamida Cell Ltd.
  • SEC710d
    SEC Form EFFECT filed by Gamida Cell Ltd.
  • SEC713d
    Gamida Cell Ltd. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits (Amendment)
  • SEC714d
    SEC Form S-8 POS filed by Gamida Cell Ltd.
  • SEC714d
    SEC Form S-8 POS filed by Gamida Cell Ltd.
  • SEC714d
    SEC Form S-8 POS filed by Gamida Cell Ltd.
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022